Screening histories of invasive breast cancers diagnosed 1989-2006 in the West Midlands, UK: Variation with time and impact on 10-year survival

Journal of Medical Screening

Volumn 16, Issue 4, 2009, Pages 186-192

  Lawrence, Gill ^a   O'Sullivan, Emma ^a   Kearins, Olive ^a   Tappenden, Nancy ^a   Martin, Kate ^a   Wallis, Matthew ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NIHR Cambridge Biomedical Research Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST TUMOR; FEMALE; HUMAN; MIDDLE AGED; MORTALITY; SURVIVAL RATE; UNITED KINGDOM;

BREAST NEOPLASMS; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; SURVIVAL RATE;

EID: 75149187462     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/jms.2009.009040     Document Type: Article

References (29)

1. Shapiro S. Screening: assessment of current studies. Cancer 1994;74(Suppl. 1):231-238
2. Tabar L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health & Welfare. Lancet 1985;1:829-832
3. Tabar L, Fagerberg G, Duffy SW, et al. Update of the Swedish two county program of mammographic screening for breast cancer. Radiologic Clin North Am 1992;1:187-210
4. Forrest APM. Breast Cancer Screening; Report to the Health Ministers of England, Wales, Scotland and Northern Ireland by a Working Group chaired by Professor Sir Patrick Forrest. London: HMSO, 1987
5. BASO Screening Audit Group. An Audit of Screen-detected Breast Cancers for the Year of Screening April 2006 - March 2007; NHSBSP, June 2008
6. Breast Screening Programme, England 2007-2008. The Health and Social Care Information Centre. January 2009
7. Blanks RG, Moss SM,Wallis MG. A comparison of two view and one view mammography in the detection of small invasive cancers: results from the National Health Service breast screening programme. J Med Screen 1996;4:200-203
8. Kavanagh AM, Mitchell H, Farrugia H, et al. Monitoring interval cancers in an Australian mammographic screening programme. J Med Screen 1999;6:139-143
9. Patnick J, Muir Gray JA. Guidelines on the Collection and Use of Breast Cancer Data. Sheffield: NHSBSP Publications, 1993
10. Lawrence G, Kearins O, O'Sullivan E, et al. The West Midlands breast screening status algorithm - methodology and use as an audit tool. J Med Screen 2005;12:179-184
11. National Statistics website. See http://www.statistics.gov.uk/census2001/ pyramids/pages/f.asp
12. Breast Interval Cancer Manual. Sheffield: NHSBSP Publications, 2009
13. Hakulinen T, Gibberd R, Abeywickrama KH, Söderman BA. A Computer Program Package for Cancer Survival Studies. Version 1.0. Helsinki: Cancer Society of Finland, 1988:39
14. Elandt-Johnson RC, Johnson NL, eds. Survival distributors. In: Survival Models and Data Analysis. New York: John Wiley & Sons, 1999:72-74
15. Peeters PH, Verbeek ALM, Hendriks JHCL, et al. Occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer 1989;59:929-932
16. Ikeda DM, Andersson I, Wattsgard C, et al. Interval carcinomas in the Malmo mammographic screening trial: radiographic appearance and prognostic considerations. Am J Roentgenol 1992;159:287-294
17. Day NE, McCann J, Camilleri-Ferrante C, et al. Monitoring Interval Cancers in Breast Screening Programmes: The East Anglican Experience, Quality Assurance Management Group of the East Anglican Breast Screening Programme. J Med Screen 1995;2:180-185
18. Woodman CBJ, Threlfall AG, Boggis CRM, et al. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's North Western region. BMJ 1995;310:224-226
19. Burrell HC, Sibbering DM, Wilson AR, et al. Screening interval breast cancers: mammographic features and prognosis factors. Radiology 1996;199:811-817
20. Bucchi L, Ravaioli A, Foca F, et al. Incidence of interval breast cancers after 650,000 negative mammographies in 13 Italian health districts. J Med Screen 2008;15:30-35
21. Young KC, Wallis MG, Blanks RG, et al. Influence of number of views and mammographic film density on the detection of invasive cancers: results from the NHS Breast Screening Programme. Br J Radiol 1997;70:482-488
22. Moss SM, Blanks RG for the Interval Cancer Working Group. Calculating Appropriate Target Cancer Detection Rates and Expected Interval Cancer Rates for the UK NHS Breast Screening Programme. J Epidemiol Commun Health February 1998;52:111-115
23. Tabar L, Fagerberg G, Duffy SW, et al. The Swedish Two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Commun Health 1989;43:107-114
24. Taylor R, Supramaniam R, Rikard M, et al. Interval breast cancers in New South Wales, Australia, and comparisons with other trials and other mammographic screening programmes. J Med Screen 2002;9:20-25
25. Day NE. Estimating the sensitivity of a screening test. J Epidemiol Commun Health 1985;39:364-366
26. Frachebound J, de Koning HJ, Beemsterboer PM, et al. Interval cancers in the Dutch Breast Screening Programme. Br J Cancer 1999;81:912-917
27. Coombs NJ, Taylor R, Wilken N, et al. HRT and breast cancer: impact on population risk and incidence. Eur J Cancer 2005;41:1775-1781
28. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-1059
29. Bullard J, Coleman MP, Robinson D, et al. Completeness of cancer registration: a new method for routine use. Br J Cancer 2000;82:1111-1116